Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A 18F-fluorodeoxyglucose study of a mouse model of atherosclerosis and type 2 diabetes

This publication has 33 references indexed in Scilit:

• Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
  PLOS ONE, 2012
• Impact of Noninsulin-Dependent Type 2 Diabetes on Carotid Wall 18F-Fluorodeoxyglucose Positron Emission Tomography Uptake
  JACC, 2012
• Effects of Age, Diet, and Type 2 Diabetes on the Development and FDG Uptake of Atherosclerotic Plaques
  JACC: Cardiovascular Imaging, 2011
• Determinants of FDG Uptake in Atherosclerosis⁎⁎Editorials published in JACC: Cardiovascular Imaging reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College of Cardiology.
  JACC: Cardiovascular Imaging, 2011
• Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
  Circulation, 2011
• Validation of the non-alcoholic fatty liver disease activity score
  Alimentary Pharmacology & Therapeutics, 2011
• Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice
  American Journal of Physiology-Endocrinology and Metabolism, 2011
• Vascular Inflammation in Patients With Impaired Glucose Tolerance and Type 2 Diabetes
  Circulation: Cardiovascular Imaging, 2010
• Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
  Diabetes, 2010
• Increased Atherosclerotic Lesion Calcification in a Novel Mouse Model Combining Insulin Resistance, Hyperglycemia, and Hypercholesterolemia
  Circulation Research, 2007